United Therapeutics Corp.
(NASDAQ : UTHR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
-1.01%21.651.8%$156.05m
MDCOMedicines Company
1.01%37.0021.8%$75.45m
ARQLArQule, Inc.
-0.61%10.540.7%$71.89m
JAZZJazz Pharmaceuticals Plc
1.36%136.762.3%$68.39m
PRGOPerrigo Co. Plc
-1.69%50.636.8%$61.45m
SAGESAGE Therapeutics, Inc.
-3.42%181.008.7%$52.22m
UTHRUnited Therapeutics Corporation
-0.34%75.9214.3%$50.57m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-0.17%167.386.2%$45.53m
HZNPHorizon Pharma plc
0.17%23.566.7%$42.45m
CTLTCatalent Inc
0.13%54.052.4%$41.10m
ICLRICON Plc
0.14%151.004.1%$35.44m
ICPTIntercept Pharmaceuticals, Inc.
0.70%69.7718.6%$32.39m
AXSMAxsome Therapeutics, Inc.
-0.92%25.762.1%$25.63m
PTLAPortola Pharmaceuticals, Inc.
-1.11%25.797.5%$23.63m
MNKMallinckrodt Plc
-2.02%8.2521.0%$22.14m

Company Profile

United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.